Physiol. Genomics AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Physiol. Genomics 35: 123-131, 2008. First published July 29, 2008; doi:10.1152/physiolgenomics.90225.2008
1094-8341/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures and Tables
Right arrow A corrigendum has been published
Right arrow All Versions of this Article:
35/1/123    most recent
90225.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Swift, S. M.
Right arrow Articles by Liggett, S. B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swift, S. M.
Right arrow Articles by Liggett, S. B.
Received 17 April 2008; accepted in final form 25 July 2008.
Physiological Genomics 35:123-131 (2008)
1094-8341/08 $8.00 © 2008 American Physiological Society

Differential coupling of Arg- and Gly389 polymorphic forms of the β1-adrenergic receptor leads to pathogenic cardiac gene regulatory programs

Steven M. Swift1, Brigitte R. Gaume1, Kersten M. Small2, Bruce J. Aronow3 and Stephen B. Liggett1

1 Cardiopulmonary Genomics Program, University of Maryland School of Medicine, Baltimore, Maryland
2 Merck Research Laboratories, Cardiovascular Diseases, Rahway, New Jersey
3 Division of Biomedical Informatics, Cincinnati Children's Hospital Research Foundation, University of Cincinnati College of Medicine, Cincinnati, Ohio

The β1-adrenergic receptor (β1AR; ADRB1) polymorphism Arg389Gly is located in an intracellular loop and is associated with distinct human and mouse cardiovascular phenotypes. To test the hypothesis that β1-Arg389 and β1-Gly389 alleles could differentially couple to pathways beyond that of classic Gs-adenylyl cyclase (AC)/cAMP signaling, we performed comparative gene expression profile analyses on hearts from wild-type and transgenic mice that expressed either human β1-Arg389 or β1-Gly389 receptors, or AC5, sampling at an early age prior to the onset of pathological features. All three models upregulated the expression of genes associated with RNA metabolism and translation and downregulated genes associated with mitochondria and energy metabolism, consistent with shared cAMP-driven increase in cardiac contractility, protein synthesis, and compensatory downregulation of mitochondrial energy production. Both β1AR alleles activated additional genes associated with other pathways. Uniquely, β1-Arg389 hearts exhibited upregulated expression of genes associated with inflammation, programmed cell death, and extracellular matrix. These observations expand the scope of 7-transmembrane domain receptor signaling propagation beyond known cognate G protein couplings. Moreover, they implicate alterations of a repertoire of processes evoked by a single amino acid variation in the cardiac β1AR that might be exploited for genotype-specific heart failure diagnostics and therapeutics.

polymorphism; adrenergic; heart failure; β-blocker; microarrays






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.